Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
31 August 2022 - 6:05AM
Eton Pharmaceuticals (“Eton” or “the Company”) (Nasdaq: ETON), an
innovative pharmaceutical company focused on developing and
commercializing treatments for rare diseases, today announced that
Sean Brynjelsen, Chief Executive Officer, will present at the H.C.
Wainwright 24th Annual Global Investment Conference as
follows:
Date: |
Wednesday,
September 14, 2022 |
Time: |
1:30PM ET |
Webcast: |
Click Here |
The webcast will be accessible via the Company’s website at
https://ir.etonpharma.com/ the Investors section under Events and
Presentations.
Eton will be participating in 1x1 meetings, which can be
requested via H.C. Wainwright.
About Eton PharmaceuticalsEton Pharmaceuticals,
Inc. is an innovative pharmaceutical company focused on developing
and commercializing treatments for rare diseases. The Company
currently commercializes ALKINDI SPRINKLE® and Carglumic Acid
tablets and has two additional rare disease products under
development, dehydrated alcohol injection and the ZENEO®
hydrocortisone autoinjector. In addition, the Company is entitled
to receive milestone payments or royalties on seven different
products.
Investor Relations:Lisa M. Wilson, In-Site
Communications, Inc.T: 212-452-2793E: lwilson@insitecony.com
Source: Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals (NASDAQ:ETON)
Historical Stock Chart
From Mar 2024 to Apr 2024
Eton Pharmaceuticals (NASDAQ:ETON)
Historical Stock Chart
From Apr 2023 to Apr 2024